In the BioHarmony Drug Report Database
Miglitol
Glyset (miglitol) is a small molecule pharmaceutical. Miglitol was first approved as Glyset on 1996-12-18. It is used to treat type 2 diabetes mellitus in the USA. The pharmaceutical is active against maltase-glucoamylase, intestinal and lysosomal alpha-glucosidase.
Trade Name
|
Glyset |
|---|---|
Common Name
|
miglitol |
ChEMBL ID
|
CHEMBL1561 |
Indication
|
type 2 diabetes mellitus |
Drug Class
|
Image (chem structure or protein)